People learn what to expect from the systems they inhabit. Classic sociological work has long made that point in different ways. Pierre Bourdieu argued that social conditions shape a habitus — durable dispositions that influence how people perceive, judge, and act. Edward T. Hall argued that even personal space is not natural but shaped by culture and social setting. Susan Leigh Star made a similar point about infrastructure, arguing that it shapes and is shaped by the conventions of a community of practice. The broader lesson is that routines, material limits, and institutional design do more than organize behavior; they shape expectations. Over time, they teach people what feels ordinary, what feels excessive, what seems worth waiting for, and what kinds of constraint register as legitimate.
Health care is no exception. American and European health care systems do not just finance care differently or ration it differently. They shape what patients think medicine is supposed to provide, what providers come to regard as routine care, and when limits register as judgment rather than obstruction. That difference helps explain why denials are so inflammatory in the United States. The issue is not just the denial itself. It is about the horizon of care the system has established before any denial occurs.
A companion piece explored the psychological and behavioral economic dynamics that make denials so difficult to accept — loss aversion, reactance, procedural fairness, and the force of identifiable cases. The focus of this article is different: how the structure of American health care helps to produce the expectations that make those reactions so common in the first place.
How the U.S. expands the horizon of care
In the United States, patients and providers operate in a system that makes medicine feel expansive, full of options, and easy to escalate. The logic of the system points toward more: more testing, more specialist involvement, more treatment pathways. Patients are socialized into that logic through ordinary signals of American medical culture. Direct-to-consumer advertising invites them to think of prescription drugs as things to ask for by name. A consumer-facing medical culture encourages the public to see itself not just as people seeking guidance, but as consumers choosing among options.
Providers are shaped by the same environment. They train and practice in a setting where advanced imaging, specialist referrals, and multiple treatment pathways are more available and more readily considered. Over time, abundance comes to feel less like an exception than a baseline. A referral, a scan, or another intervention can come to seem less like a meaningful escalation than part of the ordinary menu of care.
Where restraint enters the pathway
A useful contrast comes from systems that place more restraint upstream. While European health systems vary considerably, several of them — especially the Netherlands, England, Italy, Denmark, Norway, Spain, and Portugal — place more limits earlier in the care pathway than the United States does, with primary care playing a stronger gatekeeping role and specialist access more often mediated through referral.
Relative to the large and explicit U.S. literature on prior authorization and denials, the evidence on European patient and provider satisfaction with upstream gatekeeping appears thinner. That does not prove the burden is absent. But it is at least suggestive that upstream limits may be experienced as a smaller and less combustible problem than downstream utilization-management restrictions are in the United States. One reason may be that such limits are more often absorbed into ordinary practice rather than cast as a distinct source of conflict. Where they are experienced as a burden, that burden may also be less politically charged and less socially salient than downstream restrictions are in the United States.
That difference in placement matters. When limits are built into ordinary clinical judgment, they feel more like triage. When they arrive later, after testing, referral, or treatment has already been established as the next step, they feel more like denial.
This also helps explain why the American conflict over denials is not simply a conflict between demanding patients and cost-conscious payers. In the United States, providers work within a system in which broad availability and escalation have come to feel routine. When a payer later rejects a request, it is often interrupting a pathway that both patient and provider have come to see as standard and reasonable.
More care, more denials, more conflict
A separate point is that a high-utilization system does not just deliver more care. It also creates more points at which care can be reviewed, questioned, or denied. More testing, more referrals, and more treatment pathways do not simply increase utilization; they increase the number of points at which someone may have to say “no.” In that sense, the United States does not just have a denial problem. It has a system that produces more occasions for denial in the first place.
More denial events also mean more conflict, and more conflict means greater awareness. A system that produces repeated moments of refusal will generate more patient stories, more provider frustration, more media coverage, and more political attention. Over time, denial becomes not just something that happens in isolated cases, but a publicly recognizable feature of the system itself. That visibility then feeds back into expectations: Patients and providers come to expect interference and to interpret limits as adversarial rather than ordinary.
What health care systems teach
The deeper contrast between the United States and several European systems is not simply that one spends more or that another denies less. It is that they cultivate different assumptions about what health care is for. In the United States, care is more likely to be experienced as expansive and open-ended. In systems with stronger gatekeeping and more limits built into care, it is more likely to be experienced as professionally mediated, structured by shared limits, and guided by stewardship. These are not just administrative differences. They reflect different norms, expectations, and institutional structures. They shape what patients feel entitled to seek, what providers feel entitled to order, and what both sides experience as fairness.
The problem is not only that a high-utilization system produces more occasions for denial. It is that it produces a culture of anger over those denials.
Until the United States confronts the expectations built by its own high-utilization system, denial will continue to feel uniquely illegitimate, because the system has already taught patients and providers alike to expect more than it is willing to approve.
No Comments